SCHEMBL22784384

SCHEMBL22784384

CN1CCC[C@H](OC(=O)N2CCc3ccccc3[C@@H]2c2ccc(F)cc2)C1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 11/20 0.64
KCNH2 Q12809 2/20 0.64
CHRM1 P11229 3/20 0.52
CHRM2 P08172 2/20 0.52
CHRM5 P08912 2/20 0.52
CACNA1F O60840 1/20 0.52
CHRM4 P08173 1/20 0.52
KCNE1 P15382 1/20 0.52
KCNQ1 P51787 1/20 0.52
CACNA1D Q01668 1/20 0.52
CACNA1S Q13698 1/20 0.52
CACNA1C Q13936 1/20 0.52
SCN5A Q14524 1/20 0.52
KCND3 Q9UK17 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.48
CYP2D6 P10635 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22784386 1.00 CHRM3 (0.64) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22784184 0.94 CHRM3 (0.66) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22784179 0.94 CHRM3 (0.66) CHRM3KCNH2CHRM1CHRM2CHRM5
Hydrochloric Acid SCHEMBL29560765 0.93 CHRM3 (0.65) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22784237 0.90 CHRM3 (0.68) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL23561888 0.90 CHRM3 (0.70) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22776286 0.85 CHRM3 (0.58) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22776285 0.85 CHRM3 (0.58) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22777096 0.83 CHRM3 (0.68) CHRM3KCNH2CHRM1CHRM2CHRM5
SCHEMBL22784309 0.83 CHRM3 (0.68) CHRM3KCNH2CHRM1CHRM2CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020252222-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2020-12-17 WO disclosed